1643 Stock Overview
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Modern Chinese Medicine Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.38 |
| 52 Week High | HK$0.60 |
| 52 Week Low | HK$0.28 |
| Beta | 0.39 |
| 1 Month Change | 16.92% |
| 3 Month Change | -13.64% |
| 1 Year Change | 22.58% |
| 3 Year Change | -51.28% |
| 5 Year Change | n/a |
| Change since IPO | -69.84% |
Recent News & Updates
Why Investors Shouldn't Be Surprised By Modern Chinese Medicine Group Co., Ltd.'s (HKG:1643) 28% Share Price Plunge
Jan 06
Revenues Not Telling The Story For Modern Chinese Medicine Group Co., Ltd. (HKG:1643) After Shares Rise 32%
Nov 11Modern Chinese Medicine Group's (HKG:1643) Conservative Accounting Might Explain Soft Earnings
Sep 30Recent updates
Why Investors Shouldn't Be Surprised By Modern Chinese Medicine Group Co., Ltd.'s (HKG:1643) 28% Share Price Plunge
Jan 06Revenues Not Telling The Story For Modern Chinese Medicine Group Co., Ltd. (HKG:1643) After Shares Rise 32%
Nov 11Modern Chinese Medicine Group's (HKG:1643) Conservative Accounting Might Explain Soft Earnings
Sep 30Modern Chinese Medicine Group Co., Ltd. (HKG:1643) Stock Catapults 25% Though Its Price And Business Still Lag The Market
May 22Lacklustre Performance Is Driving Modern Chinese Medicine Group Co., Ltd.'s (HKG:1643) Low P/E
Mar 25We Think You Should Be Aware Of Some Concerning Factors In Modern Chinese Medicine Group's (HKG:1643) Earnings
Sep 02Calculating The Fair Value Of Modern Chinese Medicine Group Co., Ltd. (HKG:1643)
Jun 07Shareholder Returns
| 1643 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | 0% | 2.7% | 2.9% |
| 1Y | 22.6% | 5.7% | 26.3% |
Return vs Industry: 1643 exceeded the Hong Kong Pharmaceuticals industry which returned 3.5% over the past year.
Return vs Market: 1643 underperformed the Hong Kong Market which returned 24.5% over the past year.
Price Volatility
| 1643 volatility | |
|---|---|
| 1643 Average Weekly Movement | 14.1% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in HK Market | 13.8% |
| 10% least volatile stocks in HK Market | 3.0% |
Stable Share Price: 1643's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1643's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 190 | Hongli Zhang | www.cdysjdyy.com |
Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China. The company offers vigour and vitality supplement, circulation enhancement, kidney invigoration, menstrual discomfort relief, huoxiang zheng qi, liver-dispersing and stomach regulating, and fever- removing and detoxification pills; cardiotonic enhancement and heart wellness capsules; and liver detox tablets. It offers its products as therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and respiratory system conditions.
Modern Chinese Medicine Group Co., Ltd. Fundamentals Summary
| 1643 fundamental statistics | |
|---|---|
| Market cap | HK$228.00m |
| Earnings (TTM) | HK$15.35m |
| Revenue (TTM) | HK$257.16m |
14.9x
P/E Ratio0.9x
P/S RatioIs 1643 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1643 income statement (TTM) | |
|---|---|
| Revenue | CN¥240.61m |
| Cost of Revenue | CN¥173.96m |
| Gross Profit | CN¥66.65m |
| Other Expenses | CN¥52.29m |
| Earnings | CN¥14.36m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.024 |
| Gross Margin | 27.70% |
| Net Profit Margin | 5.97% |
| Debt/Equity Ratio | 0.1% |
How did 1643 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 09:05 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Modern Chinese Medicine Group Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.